1-5 of 5
Pamela Shaw
Close
Sort by
Journal Articles

Randomized, Phase II Dose Optimization Study of Chimeric Antigen Receptor Modified T Cells Directed Against CD19 (CTL019) in Patients with Relapsed, Refractory CLL

David L. Porter, MD, Noelle V. Frey, MDMS, J. Joseph Melenhorst, PhD, Wei-Ting Hwang, PhD, Simon F. Lacey, PhD BSc, Pamela Shaw, PhD, Anne Chew, PhD, Stephan A. Grupp, MD PhD, James Capobianchi, Joan Gilmore, Michael Kalos, PhD, Manuel Litchman, MD, Lester Lledo, RN,MSN,CNP, Alison Wakoff Loren, MDMS, Yolanda Mahnke, PhD, Katherine T. Marcucci, PhD, Holly McConville, RN, Angela Shen, MD, Patricia A. Wood, MD PhD, Zhaohui Zheng, Bruce L. Levine, PhD, Carl H. June, MD
Journal: Blood
Blood (2014) 124 (21): 1982.
https://doi.org/10.1182/blood.V124.21.1982.1982
Published: 2014
Journal Articles

Cytokine Release Syndrome (CRS) after Chimeric Antigen Receptor (CAR) T Cell Therapy for Relapsed/Refractory (R/R) CLL

David L. Porter, MD, Simon F. Lacey, PhD BSc, Wei-Ting Hwang, PhD, Pamela Shaw, PhD, Noelle V. Frey, MDMS, Anne Chew, PhD, Fang Chen, PhD, Michael Kalos, PhD, Vanessa Gonzalez, PhD, Katherine T. Marcucci, PhD, Shannon L Maude, MD PhD, Jan J Melenhorst, PhD, Manuel Litchman, MD, David T. Teachey, MD, Angela Shen, MD, Alfonso Quintas-Cardamas, MD, Patricia A. Wood, MD PhD, Bruce L. Levine, PhD, Carl H. June, MD, Stephan A. Grupp, MD PhD
Journal: Blood
Blood (2014) 124 (21): 1983.
https://doi.org/10.1182/blood.V124.21.1983.1983
Published: 2014
Journal Articles

Refractory Cytokine Release Syndrome in Recipients of Chimeric Antigen Receptor (CAR) T Cells

Noelle V. Frey, MDMS, Bruce L. Levine, PhD, Simon F. Lacey, PhD BSc, Stephan A. Grupp, MD PhD, Shannon L Maude, MD PhD, Stephen J. Schuster, MD, Pamela Shaw, PhD, Wei-Ting Hwang, PhD, Mariusz A. Wasik, MD, Amrom Obstfeld, MD, Mimi Leung, MPH, Angela Shen, MD, Solveig G. Ericson, MD PhD, Jan J Melenhorst, PhD, Carl H. June, MD, David Porter, MD
Journal: Blood
Blood (2014) 124 (21): 2296.
https://doi.org/10.1182/blood.V124.21.2296.2296
Published: 2014
Journal Articles

T Cells Engineered with a Chimeric Antigen Receptor (CAR) Targeting CD19 (CTL019) Have Long Term Persistence and Induce Durable Remissions in Children with Relapsed, Refractory ALL

Stephan A. Grupp, MD PhD, Shannon L Maude, MD PhD, Pamela Shaw, PhD, Richard Aplenc, MD PhD, David M. Barrett, MDPhD, Colleen Callahan, MSN, CRNP, Anne Chew, PhD, Simon F. Lacey, PhD BSc, Bruce L. Levine, PhD, J. Joseph Melenhorst, PhD, Laura Motley, RN, BSN, Susan R. Rheingold, MD, Angela Shen, MD, David T. Teachey, MD, Patricia A. Wood, MD PhD, David L Porter, MD, Carl H. June, MD
Journal: Blood
Blood (2014) 124 (21): 380.
https://doi.org/10.1182/blood.V124.21.380.380
Published: 2014
Journal Articles

Causes and Consequences of Splenectomy In ALPS-FAS

Susan Price, Pamela Shaw, Jennifer Kirk, Joie Davis, Katie Perkins, Fred Gill, Thomas Fleisher, V. Koneti Rao
Journal: Blood
Blood (2010) 116 (21): 3908.
https://doi.org/10.1182/blood.V116.21.3908.3908
Published: 2010